| Authors: |
Heindel P; Divisions of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Yu P; Divisions of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Feliz JD; Divisions of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Hentschel DM; Interventional Nephrology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Burke SK; Akebia Therapeutics, Cambridge, MA., Al-Omran M; Division of Vascular Surgery, University of the Toronto, Toronto, ON, Canada.; Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of the Toronto, Toronto, ON, Canada.; Department of Surgery, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia., Bhatt DL; Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Belkin M; Divisions of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Ozaki CK; Divisions of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Hussain MA; Divisions of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. |